BioSpace News Archive

Business

BioLife Solutions Executes Additional Long-Term Supply Agreement with Leading T Cell Therapy Customer

BioLife Solutions today announced that it has executed a new confidential agreement to supply its proprietary CryoStor cell freeze media to a leading T cell therapy customer.

November 29, 2017

·

4 min read

Policy

Capricor Therapeutics Announces FDA Clearance of IND Application for CAP-1002

This randomized, double-blind, placebo-controlled clinical trial will be called the HOPE-2 Trial.

November 29, 2017

·

6 min read

CALIXAR and AstraZeneca to Publish New Insight on KCC2 Architecture and Function

This study describes the use of calixarene-based detergent to solubilize and purify full-length non-aggregated and homogenous KCC2.

November 29, 2017

·

2 min read

Drug Development

RXi Pharma Announces Positive Results With RXI-231 in Consumer Testing Program

The results from the completed consumer testing program, in combination with previously announced preclinical data on melanin content in cultured melanocytes and 3-dimensional reconstituted human skin models, show that RXI-231 has the potential to reduce skin pigmentation induced by UV exposure in vivo.

November 29, 2017

·

5 min read

Business

TM3 Therapeutics Appoints Peter Van Vlasselaer as Chairman of the Board

Dr. Van Vlasselaer is currently Chief Executive Officer of ARMO Biosciences.

November 29, 2017

·

4 min read

Business

Immunomic Therapeutics’ Founder Appointed to Maryland Life Sciences Advisory Board

The LSAB was created in 2007 to assist in maintaining Maryland’s strong presence in the life sciences industry.

November 29, 2017

·

3 min read

Intrexon Enters Into $100M Preferred Stock Equity

BioForest

Frazier-Backed Mavupharma Scores $20M to Fund STING Program

The Series A funding will be used primarily to advance Mavu’s lead drug candidates into the clinic.

November 29, 2017

·

2 min read

Lone Star Bio

Silicon Labs Biosensors Add ECG Measurement for Advanced Heart Rate Monitoring in Wearables

The new Si117x sensor modules combine ultra-low power, high sensitivity and exceptional integration, making them ideal for smart watches and wrist-based, patch-type and other wearables requiring long battery life and enhanced HRM accuracy.

November 29, 2017

·

5 min read

Drug Development

Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable Profile to Lower Serum Uric Acid in Phase-1 Study

NC-2500 showed favorable urate-lowering properties which may make a difference in gout treatment.

November 29, 2017

·

2 min read

Drug Development

Ipsen Announces Publication in Neurology of Results of Two Studies Demonstrating the Efficacy and Safety Of Dysport (Abobotulinumtoxina) in Adult Patients With Lower Limb Spasticity

Results led to regulatory approval of Dysport for the treatment of lower limb spasticity in adults in the U.S. in 2017 and in some European countries in 2016.

November 29, 2017

·

19 min read